{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:20:12Z","timestamp":1791861612415,"version":"4.3.4"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/mot.0000000000000074","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T16:52:43Z","timestamp":1398271963000},"page":"283-292","source":"Crossref","is-referenced-by-count":36,"title":["Thrombotic microangiopathy in renal allografts"],"prefix":"10.1097","volume":"19","author":[{"given":"Tibor","family":"Nadasdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-13-20211004","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/ndt\/gfs279","article-title":"Thrombotic microangiopathy and associated renal disorders.","volume":"27","author":"Barbour","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R3-13-20211004","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"R4-13-20211004","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","article-title":"A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.","volume":"70","author":"Besbas","year":"2006","journal-title":"Kidney Int"},{"key":"R5-13-20211004","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome.","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"key":"R6-13-20211004","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.semnephrol.2010.06.006","article-title":"Genetics and genetic testing in hemolytic uremic syndromethrombotic thrombocytopenic purpura.","volume":"30","author":"Noris","year":"2010","journal-title":"Semin Nephrol"},{"key":"R7-13-20211004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.","volume":"25","author":"Bu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R8-13-20211004","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation.","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"key":"R9-13-20211004","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States.","volume":"42","author":"Reynolds","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R10-13-20211004","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-13-20211004","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1055\/s-0030-1262887","article-title":"Transplantation in atypical hemolytic uremic syndrome.","volume":"36","author":"Kavanagh","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"R12-13-20211004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-2369-13-164","article-title":"End-stage kidney disease due to haemolytic uraemic syndrome: outcomes in 241 consecutive ANZDATA registry cases.","volume":"13","author":"Tang","year":"2012","journal-title":"BMC Nephrol"},{"key":"R13-13-20211004","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.transproceed.2007.08.021","article-title":"Recurrence of hemolytic uremic syndrome after renal transplantation.","volume":"39","author":"Seitz","year":"2007","journal-title":"Transplant Proc"},{"key":"R14-13-20211004","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1399-3046.2008.00910.x","article-title":"Hemolytic uremic syndrome recurrence after renal transplantation.","volume":"12","author":"Loirat","year":"2008","journal-title":"Pediatr Transplant"},{"key":"R15-13-20211004","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00467-009-1137-6","article-title":"Disease recurrence in paediatric renal transplantation.","volume":"24","author":"Cochat","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R16-13-20211004","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.ajkd.2008.06.027","article-title":"Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.","volume":"53","author":"Chan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R17-13-20211004","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am J Transplant"},{"key":"R18-13-20211004","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1600-6143.2007.01888.x","article-title":"Recurrence of HUS due to CD46MCP mutation after renal transplantation: a role for endothelial microchimerism.","volume":"7","author":"Fremeaux-Bacchi","year":"2007","journal-title":"Am J Transplant"},{"key":"R19-13-20211004","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor protein CD46 mutations in atypical hemolytic uremic syndrome.","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R20-13-20211004","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R21-13-20211004","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1600-6143.2009.02586.x","article-title":"Anti-factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome.","volume":"9","author":"Le Quintrec","year":"2009","journal-title":"Am J Transplant"},{"key":"R22-13-20211004","first-page":"3811","article-title":"Three kidneys, two diseases, one antibody Nephrol Dial T","volume":"26","author":"Lorcy","year":"2011","journal-title":"ransplant"},{"key":"R23-13-20211004","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-6143.2009.02870.x","article-title":"Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.","volume":"10","author":"Waters","year":"2010","journal-title":"Am J Transplant"},{"key":"R24-13-20211004","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2369-14-156","article-title":"Long term follow up of congenital thrombotic thrombocytopenic purpura Upshaw-Schulman syndrome on hemodialysis for 19 years: a case report.","volume":"14","author":"Mise","year":"2013","journal-title":"BMC Nephrol"},{"key":"R25-13-20211004","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1538-7933.2004.00623.x","article-title":"Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura Upshaw-Schulman syndrome.","volume":"2","author":"Veyradier","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R26-13-20211004","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/j.1600-6143.2005.01035.x","article-title":"Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature.","volume":"5","author":"Pham","year":"2005","journal-title":"Am J Transplant"},{"key":"R27-13-20211004","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1600-6143.2010.03233.x","article-title":"Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies.","volume":"10","author":"Canaud","year":"2010","journal-title":"Am J Transplant"},{"key":"R28-13-20211004","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/ajt.12319","article-title":"Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes.","volume":"13","author":"Canaud","year":"2013","journal-title":"Am J Transplant"},{"key":"R29-13-20211004","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.transproceed.2012.07.039","article-title":"De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.","volume":"44","author":"Caires","year":"2012","journal-title":"Transplant Proc"},{"key":"R30-13-20211004","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","article-title":"De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection.","volume":"10","author":"Satoskar","year":"2010","journal-title":"Am J Transplant"},{"key":"R31-13-20211004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R32-13-20211004","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000478-199603000-00007","article-title":"Microvascular changes in renal allografts associated with FK506 Tacrolimus therapy.","volume":"20","author":"Randhawa","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R33-13-20211004","first-page":"101","article-title":"Morphological patterns in cyclosporine-treated renal transplant recipients.","volume":"17","author":"Mihatsch","year":"1985","journal-title":"Transplant Proc"},{"key":"R34-13-20211004","first-page":"225","article-title":"Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.","volume":"94","author":"Sibley","year":"1983","journal-title":"Surgery"},{"key":"R35-13-20211004","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0272-6386(96)90468-0","article-title":"Cyclosporine-associated thrombotic microangiopathyhemolytic uremic syndrome following kidney and kidney-pancreas transplantation.","volume":"28","author":"Young","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R36-13-20211004","first-page":"181","article-title":"Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A.","volume":"47","author":"Zent","year":"1997","journal-title":"Clin Nephrol"},{"key":"R37-13-20211004","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1046\/j.1523-1755.1999.00492.x","article-title":"Cyclosporine-associated thrombotic microangiopathy in renal allografts.","volume":"55","author":"Zarifian","year":"1999","journal-title":"Kidney Int"},{"key":"R38-13-20211004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(89)80032-0","article-title":"Renal vascular and thrombotic effects of cyclosporine.","volume":"13","author":"Remuzzi","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"R39-13-20211004","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/ndt\/gfl836","article-title":"Cyclosporine enhances platelet procoagulant activity.","volume":"22","author":"Tomasiak","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R40-13-20211004","first-page":"251S","article-title":"Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology Transplant P","volume":"36","author":"Morozumi","year":"2004","journal-title":"roc"},{"key":"R41-13-20211004","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1681\/ASN.2012111064","article-title":"Cyclosporine induces endothelial cell release of complement-activating microparticles.","volume":"24","author":"Renner","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R42-13-20211004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11255-010-9755-2","article-title":"Thrombotic thrombocytopenic purpura associated with everolimus use in a renal transplant patient.","volume":"43","author":"Yilmaz","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"R43-13-20211004","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.bbmt.2013.07.001","article-title":"Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide.","volume":"19","author":"Carmona","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R44-13-20211004","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2012.12.018","article-title":"Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation.","volume":"61","author":"Habib","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R45-13-20211004","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbrc.2011.03.086","article-title":"The inhibition of MAPK potentiates the antiangiogenic efficacy of mTOR inhibitors.","volume":"407","author":"Dormond-Meuwly","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-13-20211004","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2215\/CJN.05870710","article-title":"Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.","volume":"6","author":"Meehan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R47-13-20211004","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.transproceed.2012.09.038","article-title":"Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports.","volume":"44","author":"Gonzalez-Roncero","year":"2012","journal-title":"Transplant Proc"},{"key":"R48-13-20211004","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1681\/ASN.V101146","article-title":"Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients.","volume":"10","author":"Baid","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R49-13-20211004","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-0012.2010.01272.x","article-title":"A case of pregnancy-induced thrombotic thrombocytopenic purpura with a kidney allograft recipient.","volume":"24","author":"Iwami","year":"2010","journal-title":"Clin Transplant"},{"key":"R50-13-20211004","first-page":"137","article-title":"Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis.","volume":"6","author":"Ardalan","year":"2008","journal-title":"Exp Clin Transplant"},{"key":"R51-13-20211004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nephro.2011.06.001","article-title":"Parvovirus B19 infection after kidney transplantation.","volume":"8","author":"Brodin-Sartorius","year":"2012","journal-title":"Nephrol Ther"},{"key":"R52-13-20211004","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.V1161132","article-title":"Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation.","volume":"11","author":"Murer","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R53-13-20211004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000321328","article-title":"De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss.","volume":"32","author":"De Keyzer","year":"2010","journal-title":"Am J Nephrol"},{"key":"R54-13-20211004","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.transproceed.2011.11.052","article-title":"Spectrum of cytomegalovirus-induced renal pathology in renal allograft recipients.","volume":"44","author":"Rane","year":"2012","journal-title":"Transplant Proc"},{"key":"R55-13-20211004","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am J Transplant"},{"key":"R56-13-20211004","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0272-6386(12)81010-9","article-title":"Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy.","volume":"23","author":"Hochstetler","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R57-13-20211004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1399-0012.1997.tb00798.x","article-title":"Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.","volume":"11","author":"Wiener","year":"1997","journal-title":"Clin Transplant"},{"key":"R58-13-20211004","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/j.1600-6143.2010.03267.x","article-title":"The molecular phenotype of kidney transplants.","volume":"10","author":"Halloran","year":"2010","journal-title":"Am J Transplant"},{"key":"R59-13-20211004","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1600-6143.2012.04344.x","article-title":"Precision diagnostics in transplantation: from bench to bedside.","volume":"13","author":"Mengel","year":"2013","journal-title":"Am J Transplant"},{"key":"R60-13-20211004","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/TP.0b013e31827e6b45","article-title":"Endothelial injury in renal antibody-mediated allograft rejection: a schematic view based on pathogenesis.","volume":"95","author":"Drachenberg","year":"2013","journal-title":"Transplantation"},{"key":"R61-13-20211004","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/TP.0b013e318291a298","article-title":"Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy.","volume":"95","author":"Agustian","year":"2013","journal-title":"Transplantation"},{"key":"R62-13-20211004","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ki.2011.192","article-title":"Transplant glomerulopathy: its not always about chronic rejection.","volume":"80","author":"Haas","year":"2011","journal-title":"Kidney Int"},{"key":"R63-13-20211004","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.ajkd.2012.10.026","article-title":"Advances in the understanding of transplant glomerulopathy.","volume":"62","author":"Husain","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R64-13-20211004","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1600-6143.2007.01836.x","article-title":"Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause.","volume":"7","author":"Sis","year":"2007","journal-title":"Am J Transplant"},{"key":"R65-13-20211004","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ki.2011.194","article-title":"3rd, Pascual M, et al. Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy.","volume":"80","author":"Baid-Agrawal","year":"2011","journal-title":"Kidney Int"},{"key":"R66-13-20211004","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/modpathol.3880461","article-title":"The value of electron microscopy in the diagnosis of chronic renal allograft rejection.","volume":"14","author":"Ivanyi","year":"2001","journal-title":"Mod Pathol"},{"key":"R67-13-20211004","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/j.1600-6143.2011.03647.x","article-title":"Early ultrastructural changes in renal allografts: correlation with antibody mediated rejection and transplant glomerulopathy.","volume":"11","author":"Haas","year":"2011","journal-title":"Am J Transplant"},{"key":"R68-13-20211004","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/j.1600-6143.2007.01995.x","article-title":"Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies.","volume":"7","author":"Wavamunno","year":"2007","journal-title":"Am J Transplant"},{"key":"R69-13-20211004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/ctr.12170","article-title":"Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.","volume":"27","author":"Koppula","year":"2013","journal-title":"Clin Transplant"},{"key":"R70-13-20211004","doi-asserted-by":"crossref","first-page":"260254","DOI":"10.1155\/2013\/260254","article-title":"Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy.","volume":"2013","author":"Cicora","year":"2013","journal-title":"Case Rep Med"},{"key":"R71-13-20211004","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-6143.2008.02482.x","article-title":"Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy.","volume":"9","author":"Ashman","year":"2009","journal-title":"Am J Transplant"},{"key":"R72-13-20211004","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2741\/196","article-title":"Histopathology and outcome of acute humoral rejection in renal allografts.","volume":"3","author":"Satoskar","year":"2011","journal-title":"Front Biosci"},{"key":"R73-13-20211004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2012.07.028","article-title":"Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.","volume":"61","author":"Schmidtko","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R74-13-20211004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trre.2013.07.003","article-title":"Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation.","volume":"27","author":"Zuber","year":"2013","journal-title":"Transplant Rev"},{"key":"R75-13-20211004","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1016\/j.transproceed.2012.07.141","article-title":"Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.","volume":"44","author":"Xie","year":"2012","journal-title":"Transplant Proc"},{"key":"R76-13-20211004","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/TP.0b013e3182a7fccd","article-title":"Successful treatment of acute thrombotic microangiopathy by eculizumab after combined lung and kidney transplantation.","volume":"96","author":"Commereuc","year":"2013","journal-title":"Transplantation"},{"key":"R77-13-20211004","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.","volume":"12","author":"Zuber","year":"2012","journal-title":"Am J Transplant"},{"key":"R78-13-20211004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00467-013-2591-8","article-title":"Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFHCFHR1 hybrid gene.","volume":"29","author":"Roman-Ortiz","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R79-13-20211004","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/TP.0b013e31829d388d","article-title":"Anti-C5 as prophylactic therapy in atypical hemolytic uremic syndrome in living-related kidney transplantation.","volume":"96","author":"Pelicano","year":"2013","journal-title":"Transplantation"},{"key":"R80-13-20211004","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1600-6143.2011.03696.x","article-title":"Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation.","volume":"11","author":"Hadaya","year":"2011","journal-title":"Am J Transplant"},{"key":"R81-13-20211004","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/TP.0b013e318230c0bd","article-title":"Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab.","volume":"92","author":"Wilson","year":"2011","journal-title":"Transplantation"},{"key":"R82-13-20211004","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2741\/e426","article-title":"Endothelial microparticles in transplant patients: great potential but a long way to go.","volume":"4","author":"Brodsky","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"R83-13-20211004","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2215\/CJN.02170508","article-title":"Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.","volume":"4","author":"Saland","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201406000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T14:45:21Z","timestamp":1746197121000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201406000-00013"}},"subtitle":["the diagnostic challenge"],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0000000000000074","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}